Your browser doesn't support javascript.
loading
Development and Multicenter Case-Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction.
Salari, Keyan; Sundi, Debasish; Lee, Jason J; Wu, Shulin; Wu, Chin-Lee; DiFiore, Gabrielle; Yan, Q Robert; Pienkny, Andrew; Lee, Chi K; Oberlin, Daniel; Barme, Greg; Piser, Joel; Kahn, Robert; Collins, Edward; Phillips, Kevin G; Caruso, Vincent M; Goudarzi, Mahdi; Garcia-Ransom, Monica; Lentz, Peter S; Evans-Holm, Martha E; MacBride, Andrew R; Fischer, Daniel S; Haddadzadeh, Iden J; Mazzarella, Brian C; Gray, Joe W; Koppie, Theresa M; Bicocca, Vincent T; Levin, Trevor G; Lotan, Yair; Feldman, Adam S.
Afiliación
  • Salari K; Department of Urology, Massachusetts General Hospital, Boston, Massachusetts.
  • Sundi D; Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Lee JJ; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Wu S; Department of Urology, The Ohio State University Comprehensive Cancer Center & Pelotonia Institute for Immuno-Oncology, Columbus, Ohio.
  • Wu CL; Department of Urology, Massachusetts General Hospital, Boston, Massachusetts.
  • DiFiore G; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.
  • Yan QR; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.
  • Pienkny A; Department of Urology, The Ohio State University Comprehensive Cancer Center & Pelotonia Institute for Immuno-Oncology, Columbus, Ohio.
  • Lee CK; Golden Gate Urology, Oakland, Berkeley and San Francisco, California.
  • Oberlin D; Golden Gate Urology, Oakland, Berkeley and San Francisco, California.
  • Barme G; Golden Gate Urology, Oakland, Berkeley and San Francisco, California.
  • Piser J; Golden Gate Urology, Oakland, Berkeley and San Francisco, California.
  • Kahn R; Golden Gate Urology, Oakland, Berkeley and San Francisco, California.
  • Collins E; Golden Gate Urology, Oakland, Berkeley and San Francisco, California.
  • Phillips KG; Golden Gate Urology, Oakland, Berkeley and San Francisco, California.
  • Caruso VM; Golden Gate Urology, Oakland, Berkeley and San Francisco, California.
  • Goudarzi M; Convergent Genomics, South San Francisco, California.
  • Garcia-Ransom M; Convergent Genomics, South San Francisco, California.
  • Lentz PS; Convergent Genomics, South San Francisco, California.
  • Evans-Holm ME; Convergent Genomics, South San Francisco, California.
  • MacBride AR; Convergent Genomics, South San Francisco, California.
  • Fischer DS; Convergent Genomics, South San Francisco, California.
  • Haddadzadeh IJ; Convergent Genomics, South San Francisco, California.
  • Mazzarella BC; Convergent Genomics, South San Francisco, California.
  • Gray JW; Convergent Genomics, South San Francisco, California.
  • Koppie TM; Convergent Genomics, South San Francisco, California.
  • Bicocca VT; Oregon Health & Science University, Portland, Oregon.
  • Levin TG; Oregon Health & Science University, Portland, Oregon.
  • Lotan Y; Willamette Urology, Salem, Oregon.
  • Feldman AS; Convergent Genomics, South San Francisco, California.
Clin Cancer Res ; 29(18): 3668-3680, 2023 09 15.
Article en En | MEDLINE | ID: mdl-37439796
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article